Sign In
Buy BNGO
$1.30
+0.0400 (+3.17%)
At Close: Jun 03, 2026
Bionano Genomics Shares Rally On Nasdaq Extension
04:50pm, Thursday, 31'st Dec 2020
Shares of BioNano Genomics Inc (NASDAQ: BNGO) have doubled in price through the last two trading days. Before the rally, Bionano Genetics was struggling to maintain the $1-per-share price that is req
Bionano Genomics Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule
08:00am, Wednesday, 30'th Dec 2020
SAN DIEGO, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that Nasdaq has granted the Company an additional 180-day compliance period, or until June 28, 2021,
BNGO Stock Price Increased 50.42%: Why It Happened
04:05am, Wednesday, 30'th Dec 2020
The stock price of BioNano Genomics Inc (NASDAQ: BNGO) increased by 50.42% as it went from a previous close of $0.88 to $1.33. This is why it happened.
SAN DIEGO, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that Praxis Genomics, LLC received accreditation from the College of American Pathologists (CAP), ma
SAN DIEGO, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the publication of a study by the Human Genome Structural Variation Consortium (HGSVC) revealing that their
SAN DIEGO, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that the performance and application of its Saphyr system for optical genome mapping are being showcased at
Bionano Genomics Reports Third Quarter 2020 Financial Results and Provides Business Update
04:01pm, Thursday, 12'th Nov 2020
Company to host conference call today, November 12, at 4:30 pm ET Company to host conference call today, November 12, at 4:30 pm ET
Multi-Center Evaluation of Bionano Optical Genome Mapping by Cytogenetics Thought Leaders in the US Leads to Recommendation for Bionano's Saphyr to Replace Karyotyping as First-Line Test for Detection and Identification of Structural and Copy Number Variants in Leukemia Patients
06:10pm, Wednesday, 11'th Nov 2020
SAN DIEGO, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the publication of a study led by cytogenetics experts from the nation's top clinical and cancer centers in
Publication from UCSF shows Bionano's optical genome mapping technology can detect pathogenic variants missed by whole exome sequencing and by chromosomal microarray in patients with rare genetic diso
Top researchers present discoveries in cancer predisposition, neurodegenerative diseases, microdeletion syndromes and other genetic disorders made using Bionano's optical genome mapping technology Top
Bionano Genomics: Intriguing Technology. Troubling Trajectory
02:14pm, Tuesday, 08'th Sep 2020
Today, we look at a very small concern with potentially game changing technology in a fast-growing part of the healthcare market.
Dr. Chaubey is a key opinion leader in cytogenetics who has developed, validated and commercialized dozens of molecular and cytogenetic tests based on next generation sequencing, microarray and COVID-
Stick With BioNano Genomics (BNGO) Stock as Consumable Revenue Growth Accelerates, Says Analyst
10:42pm, Monday, 17'th Aug 2020
2020 is turning out to be a roller-coaster ride for investors of life science company BioNano Genomics (BNGO). Over the past six trading sessions, the share price has declined by 23%. The drop, howeve
Would Shareholders Who Purchased Bionano Genomics'(NASDAQ:BNGO) Stock Year Be Happy With The Share price Today?
04:10pm, Monday, 17'th Aug 2020
It is a pleasure to report that the Bionano Genomics, Inc. (NASDAQ:BNGO) is up 81% in the last quarter. But that...
Bionano Genomics Announces “At-The-Market” Equity Program
12:30pm, Monday, 17'th Aug 2020
SAN DIEGO, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that it has filed a prospectus with the Securities and Exchange Commission (“SEC”), under which i
